[18F]fluorodeoxyglucose positron emission tomography correlates with Akt pathway activity but is not predictive of clinical outcome during mTOR inhibitor therapy

  1. Ma, W.W.
  2. Jacene, H.
  3. Song, D.
  4. Vilardell, F.
  5. Messersmith, W.A.
  6. Laheru, D.
  7. Wahl, R.
  8. Endres, C.
  9. Jimeno, A.
  10. Pomper, M.G.
  11. Hidalgo, M.
Revue:
Journal of Clinical Oncology

ISSN: 0732-183X

Année de publication: 2009

Volumen: 27

Número: 16

Pages: 2697-2704

Type: Article

DOI: 10.1200/JCO.2008.18.8383 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objetivos de desarrollo sostenible